Adenocarcinoma of the cervix represents an increasing percentage of cervical cancers as well as a controversial clinical problem. One hundred seventy-two cases of adenocarcinoma were treated at The University of Michigan Medical Center from 1970 to 1984, representing 16.8% of cervical cancers. Of this group 84 patients were diagnosed with endocervical columnar cell type and form the study population for this report. Survival was influenced by stage, grade, and nodal metastases. Age did not influence survival. Survival in stage I disease was not influenced by treatment modality. Radical surgery or radiation therapy provided equal survival and ovarian conservation did not adversely influence survival. Radical surgery can be considered a prima...
Retrospective review of medical records and autopsy findings in patients dying of squamous cell canc...
According to the epidemiological data, a tendency for rising cervical adenocarcinoma morbidity, espe...
Abstract Background: The incidence of cervical adenocarcinoma in situ is on the rise. Its detection,...
To investigate the clinicopathological characteristics and survival of squamous cell carcinoma and a...
OBJECTIVE: To determine which clinicopathological factors influence the prognosis of cervical adenoc...
Aim of the study: Analysis of prognostic factors and treatment outcomes in patients with adenocarcin...
Adenocarcinoma accounts for 10-25% of all cervical cancers, and its relative and absolute rate has r...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72534/1/j.1525-1438.1991.01040173.x.pd
Patients with squamous cell carcinoma of the cervix FIGO stages IB to IV (n = 306) were compared to ...
Adenocarcinoma of the cervix is a rare condition that has shown an increase in incidence, especially...
Objective: To determine the significance of histology and treatment modality on overall survival and...
Clear cell adenocarcinoma (CCAC) of the uterine cervix is a rare variant of cervical adenocarcinoma ...
ObjectiveTo investigate survivals from cervical cancer, with special reference to effects of glandul...
SummaryBackgroundVilloglandular adenocarcinoma (VGA) of the uterine cervix is a relatively rare subt...
From January 1, 1946, through January 1, 1986, at the University of Michigan, 60 patients were treat...
Retrospective review of medical records and autopsy findings in patients dying of squamous cell canc...
According to the epidemiological data, a tendency for rising cervical adenocarcinoma morbidity, espe...
Abstract Background: The incidence of cervical adenocarcinoma in situ is on the rise. Its detection,...
To investigate the clinicopathological characteristics and survival of squamous cell carcinoma and a...
OBJECTIVE: To determine which clinicopathological factors influence the prognosis of cervical adenoc...
Aim of the study: Analysis of prognostic factors and treatment outcomes in patients with adenocarcin...
Adenocarcinoma accounts for 10-25% of all cervical cancers, and its relative and absolute rate has r...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72534/1/j.1525-1438.1991.01040173.x.pd
Patients with squamous cell carcinoma of the cervix FIGO stages IB to IV (n = 306) were compared to ...
Adenocarcinoma of the cervix is a rare condition that has shown an increase in incidence, especially...
Objective: To determine the significance of histology and treatment modality on overall survival and...
Clear cell adenocarcinoma (CCAC) of the uterine cervix is a rare variant of cervical adenocarcinoma ...
ObjectiveTo investigate survivals from cervical cancer, with special reference to effects of glandul...
SummaryBackgroundVilloglandular adenocarcinoma (VGA) of the uterine cervix is a relatively rare subt...
From January 1, 1946, through January 1, 1986, at the University of Michigan, 60 patients were treat...
Retrospective review of medical records and autopsy findings in patients dying of squamous cell canc...
According to the epidemiological data, a tendency for rising cervical adenocarcinoma morbidity, espe...
Abstract Background: The incidence of cervical adenocarcinoma in situ is on the rise. Its detection,...